Description:
Continuous improvement of the physicochemical properties of active pharmaceutical ingredients (APIs) such as solubility, bioavailability, dissolution rate, stability, hygroscopicity, crystallinity and taste, represents an emerging area of research and development. This session focuses on the selection of solid forms including cocrystals, salts, solvates and polymorphs in crystallization processes, as well as the screening, predicting, manipulating and controlling techniques for such product selection.
Sponsor:
Crystallization and Evaporation
Chair:
Ann M. Czyzewski
Senior Scientist I
Abbott Laboratories
1401 Sheridan Rd.
North Chicago, IL 60064
Email: ann.czyzewski@abbott.com
Senior Scientist I
Abbott Laboratories
1401 Sheridan Rd.
North Chicago, IL 60064
Email: ann.czyzewski@abbott.com
Co-Chair:
Fang Wang
Senior Research Scientist
Gilead Sciences
Chemical Development
333 Lakeside drive
Foster City, CA 94404
Email: fang.wang@gilead.com
Senior Research Scientist
Gilead Sciences
Chemical Development
333 Lakeside drive
Foster City, CA 94404
Email: fang.wang@gilead.com
Papers:
See more of this Group/Topical: Separations Division
![[ Visit Client Website ]](images/banner.gif)